Home » Health » WHO Issues License to Use Novavax Vaccine, Improves Access to Vaccination in Poor Countries

WHO Issues License to Use Novavax Vaccine, Improves Access to Vaccination in Poor Countries

JAKARTA, celebrities.id World Health Organization (WHO) issued a permit to use the Covid-19 vaccine produced by the Serum Institute of India, Novavax on Friday (17/12/2021).

Thus, the company can send its vaccines for use in vaccination programs.

However, the Novavax vaccine is currently under European Medicines Agency (EMA) research. WHO said it would finalize its own assessment of vaksin Novavax, after the EMA issued its recommendations.

According to WHO, permission to use Novavax will provide a significant impetus for increasing access to Covid-19 vaccines, especially in poor countries under the Covax program.

“This list aims to improve access especially in low-income countries, 41 of which are still unable to vaccinate 10 percent of their population, while 98 countries have not reached 40 percent,” the WHO said.

– .

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.